DUBLIN, April 18, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/x4k53q/metabolomics) has announced the addition of the "Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) - Forecasts from 2012 to 2017" report to their offering.
Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, metabolomics, a new science is evolving for analyzing the basic metabolic changes taking place in a living organism. Metabolomics is thus an emerging concept which refers to the systematic study of the distinctive chemical fingerprints generated in a particular cellular process.
Metabolomics Market - Analysis of Global Technology, Application Trends and Landscape 2012-2017 report covers the market by disease indications along with the applications and metabolite profiling for biomarker discovery applications. In addition, it also includes the factors driving and restraining the market and covers the market scenario in the U.S., Europe, Asia and the Rest of the World (ROW). This report will provide the company profiles of key companies along with the competitive analysis.
The Global Metabolomics market is showing a double digit growth (CAGR 35%) due to supportive factors such as, (i) increased willingness of biotechnology and pharma companies to adopt metabolomics concept to drive R&D activity within the industry, (ii) rapid growth of metabolomics data analysis softwares and solutions, and (iii) the advancement of analytical technologies. Metabolomics is used in the identification of new biomarkers, which indicate a change in the physiological state of a cell or tissue. Biomarker screening is important in the process of new drug discovery, and is also a key in vitro diagnostics tool. Additionally it is also being used for environmental toxicology screening. While, there are major concerns of this market such as the validation challenges, the positive aspects may very well offset the market restraints to aid the market grow at an exceptional rate.
Key Topics Covered:
2. EXECUTIVE SUMMARY
3. METABOLOMICS -TECHNOLOGY LANDSCAPE ANALYSIS
4. METABOLOMICS - MARKET LANDSCAPE ANALYSIS
5. METABOLOMICS - TECHNOLOGY INVESTMENT POTENTIAL
6. METABOLOMICS - GEOGRAPHICAL ANALYSIS
7. COMPETITIVE LANDSCAPE ANALYSIS
8. PATENT ANALYSIS
9. TECHNOLOGY ANALYSIS (USING MULTI CRITERIA DECISION MAKING) & ROAD MAPPING
10 ANALYST INSIGHTS & RECOMMENDATIONS
11 COMPANY PROFILES
- AGILENT TECHNOLOGIES
- BRUKER CORPORATION
- METABOLOMIC TECHNOLOGIES
- BIO-RAD LABORATORIES
- WATERS CORPORATION
- HUMAN METABOLOME TECHNOLOGIES
- NEXTGEN METABOLOMICS
- BIOCRATES LIFE SCIENCES AG
- STEMINA BIOMARKER
- METANOMICS GMBH
- EISAI CO. LTD.
- SHIMADZU CORPORATION
- SIDMAP, LLC
- ASTRAZENECA PLC
- AB SCIEX
- RESEARCH INSTITUTE OF CHROMATOGRAPHY (RIC)
For more information visit http://www.researchandmarkets.com/research/x4k53q/metabolomics
Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices
SOURCE Research and Markets